What's breaking now, across thousands of outlets.
Paulo Fontoura took over as Sanofi’s global head of R&D in September after 16 years at Roche and a recent stint at AI drug discovery startup Xaira Therapeutics. Ahead of Sanofi’s Oct. 30 earnings, Endpoints ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
according to Elorian's evaluations, Glimpse outperforms even GPT-6 Astra on scientific chart reasoning and short-form video captioning, with competitive results on other visual reasoning tasks.
A simple mathematical formula could help researchers predict when an AI chatbot shifts from helpful answers to harmful ones, according to a new study from The George Washington University.
An AI system trained on photographs of the face and tongue correctly identified every patient with coronary heart disease (CHD) in a small test, according to a new study from China.
CoreWeave Inc. is navigating turbulent stock trends due to climbing bond yields and investor trepidation over its debt, raising fears of default.
We may be closer to understanding how AI models think, giving researchers new tools to ensure they don't go rogue.
The company flagged two new incidents as 'critical,' yet did not discover or disclose them until months later.
